Sugi Predict

Sugi Predict / Compounds / SCHEMBL7087673

SCHEMBL7087673

SCHEMBL7087673

Cc1cc(C2O[C@H]([C@H](O)CO)[C@H](O)[C@H](CO)O2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC5A2 P31639 14/20 0.40
▸ SLC5A1 P13866 4/20 0.35
▸ LGALS3 P17931 1/20 0.34
▸ SLC9A1 P19634 1/20 0.33
▸ SLC6A3 Q01959 2/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15814199 0.91 SLC5A2 (0.43) SLC5A2SLC5A1SLC6A3ABCB11ADORA3
SCHEMBL6130178 0.89 SLC5A2 (0.45) SLC5A2SLC5A1
SCHEMBL29844391 0.89 SLC5A2 (0.45) SLC5A2SLC5A1
SCHEMBL7195925 0.89 SLC5A2 (0.37) SLC5A2SLC5A1LGALS3SLC6A3CHRM1
SCHEMBL7680986 0.86 SLC5A2 (0.43) SLC5A2SLC5A1
SCHEMBL15814653 0.83 SLC5A2 (0.43) SLC5A2SLC5A1
SCHEMBL27551018 0.83 SLC5A2 (0.45) SLC5A2SLC5A1
SCHEMBL28774531 0.82 SLC5A2 (0.40) SLC5A2SLC5A1LGALS3
SCHEMBL28928268 0.82 EPHX1 (0.35) SLC5A2SLC5A1LGALS3SLC6A3ABCB11
SCHEMBL28649385 0.81 SLC5A2 (0.39) SLC5A2SLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421266-B2 Safety of pseudoephedrine drug products PISGAH LABORATORIES, INC. (US) 2016-08-23 — — US claimed
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS PISGAH LABORATORIES, INC. 2014-06-26 — — US claimed
CN-110305414-B Polyolefin composition and process for preparing the same 赣州蓝风科技有限公司 2021-11-26 — — CN disclosed
US-9421266-B2 Safety of pseudoephedrine drug products PISGAH LABORATORIES, INC. (US) 2016-08-23 — — US disclosed
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS PISGAH LABORATORIES, INC. 2014-06-26 — — US disclosed
CN-1303076-C Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same MILLIKEN & CO (US) 2007-03-07 — — CN disclosed
CN-1293079-C Process for preparing alditol acetals in high yields using mineral acids and surfactants MILLIKEN & CO (US) 2007-01-03 — — CN disclosed
CN-1511160-A Process for preparing alditol acetals in high yields using mineral acids and surfactants 美利肯公司 2004-07-07 — — CN disclosed
US-20030013786-A1 Novel asymmetric halogen-alkyl alditol derivatives as nucleators and clarifiers for polyolefins, and polyolefin plastic compositions containing same MILLIKEN & COMPANY 2003-01-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS SORD, ABCB11, ABCB1 SLC5A2 138/4885SLC5A1 75/4885LGALS3 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.